SLC43A1 and prostate carcinoma: Moreover, the specific expression levels of LAT1 and LAT3 have the value of judging the development of prostate cancer to castration-resistant prostate cancer, which can effectively guide the anti-androgen therapy of prostate cancer and predict the possibility of biochemical recurrence.